Eli Lilly LLY
NYSE LLY
$1,354.49 -10.24 (-0.75%)
At close: Nov 6, 2026 · 4:00 PM EST

Eli Lilly (LLY) Sale and Maturity of Investments (2009 - 2025)

Updated

Eli Lilly (LLY) reported Sale and Maturity of Investments - Total of $132 million for Q4 2025, up 135.7% from $56 million a year earlier but down 76.3% from the prior quarter.

Analysis

Eli Lilly (LLY) Sale and Maturity of Investments (2009 - 2025) Analysis & Trends

For FY2025, Eli Lilly posted Sale and Maturity of Investments - Total of $964 million, up 157.8% from FY2024.

  • Sale and Maturity of Investments - Total has a five-year compound annual growth rate of 1.7% (FY2020 to FY2025).
  • By year, Sale and Maturity of Investments - Total came in at $374 million in FY2024 (-26.4%), $508 million in FY2023 (+9.6%), $463.6 million in FY2022 (-45.3%) and $847.4 million in FY2021 (-4.4%).
  • Five-year quarterly Sale and Maturity of Investments - Total spans a low of -$123.4 million in Q4 2023 and a high of $556.1 million in Q3 2025.
  • Year over year, Sale and Maturity of Investments - Total has now increased in each of the last four quarters, with growth averaging 108.2% over the last seven quarters.
  • The high point for year-over-year Sale and Maturity of Investments - Total in five years was Q3 2025 (growth of 719.0%); the low point was Q1 2024 (a decline of 79.5%).
  • Per Business Quant data, the three quarters before Q4 2025 came in at $556.1 million (Q3 2025), $204.3 million (Q2 2025) and $71.6 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 308.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 315.51 Bn 288.75 Bn - 88.00 Mn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 2.53 Bn
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn 4.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 132.00 Mn
Sep 30, 2025 556.10 Mn
Jun 30, 2025 204.30 Mn
Mar 31, 2025 71.60 Mn
Dec 31, 2024 56.00 Mn
Sep 30, 2024 67.90 Mn
Jun 30, 2024 179.60 Mn
Mar 31, 2024 70.50 Mn
Dec 31, 2023 -123.40 Mn
Sep 30, 2023 133.40 Mn
Jun 30, 2023 154.60 Mn
Mar 31, 2023 343.40 Mn
Dec 31, 2022 128.90 Mn
Sep 30, 2022 108.60 Mn
Jun 30, 2022 118.00 Mn
Mar 31, 2022 108.10 Mn
Dec 31, 2021 263.60 Mn
Sep 30, 2021 100.60 Mn
Jun 30, 2021 194.40 Mn
Mar 31, 2021 288.80 Mn
API Access

Eli Lilly Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=LLY&period=max&api_key=YOUR_API_KEY